CN1161363C - 用于治疗骨质疏松症的双膦酸盐 - Google Patents

用于治疗骨质疏松症的双膦酸盐 Download PDF

Info

Publication number
CN1161363C
CN1161363C CNB988069326A CN98806932A CN1161363C CN 1161363 C CN1161363 C CN 1161363C CN B988069326 A CNB988069326 A CN B988069326A CN 98806932 A CN98806932 A CN 98806932A CN 1161363 C CN1161363 C CN 1161363C
Authority
CN
China
Prior art keywords
weight
bisphosphonic acid
amino
salt
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB988069326A
Other languages
English (en)
Chinese (zh)
Other versions
CN1261892A (zh
Inventor
¡
弗雷德·范古利科
安东尼奥·帕伦特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harry G Co Ltd
O Rod Ruge Ltd
Geange Ltd
Original Assignee
Harry G Co Ltd
O Rod Ruge Ltd
Geange Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harry G Co Ltd, O Rod Ruge Ltd, Geange Ltd filed Critical Harry G Co Ltd
Publication of CN1261892A publication Critical patent/CN1261892A/zh
Application granted granted Critical
Publication of CN1161363C publication Critical patent/CN1161363C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/5765—Six-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNB988069326A 1997-07-09 1998-07-08 用于治疗骨质疏松症的双膦酸盐 Expired - Fee Related CN1161363C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI97A01628 1997-07-09
IT97MI001628A IT1293305B1 (it) 1997-07-09 1997-07-09 Sali di acidi difosfonici e loro impiego farmacologico nel trattamento dell'osteoporosi

Publications (2)

Publication Number Publication Date
CN1261892A CN1261892A (zh) 2000-08-02
CN1161363C true CN1161363C (zh) 2004-08-11

Family

ID=11377528

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB988069326A Expired - Fee Related CN1161363C (zh) 1997-07-09 1998-07-08 用于治疗骨质疏松症的双膦酸盐

Country Status (17)

Country Link
US (1) US6410782B1 (enExample)
EP (1) EP0994884B1 (enExample)
JP (1) JP3681637B2 (enExample)
KR (1) KR100396036B1 (enExample)
CN (1) CN1161363C (enExample)
AT (1) ATE251631T1 (enExample)
AU (1) AU8806798A (enExample)
BR (1) BR9810561A (enExample)
CA (1) CA2303210A1 (enExample)
DE (1) DE69818823T2 (enExample)
DK (1) DK0994884T3 (enExample)
ES (1) ES2207853T3 (enExample)
HU (1) HUP0004679A3 (enExample)
IL (1) IL133172A (enExample)
IT (1) IT1293305B1 (enExample)
PT (1) PT994884E (enExample)
WO (1) WO1999002539A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100317935B1 (ko) * 1999-10-20 2001-12-22 유승필 대사성 골질환 치료용 약제조성물 및 이의 제조방법
CN1942184A (zh) * 2004-03-04 2007-04-04 汤浅真 包埋有金属卟啉络合物的类脂质体、其制造方法以及利用该类脂质体的药物
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
FR2926081B1 (fr) * 2008-01-03 2010-02-19 Univ Nantes Derives d'acide hydroxy-bisphosphonique comme vecteur ciblant le tissu osseux
EA201001097A1 (ru) * 2008-03-18 2011-02-28 Александр Владимирович ДИКОВСКИЙ Фармацевтическая композиция для профилактики и лечения резорбции костной ткани различной этиологии
EP2350076B1 (en) * 2008-09-22 2013-08-21 Isis Innovation Ltd Imidazo[1,2- alpha]pyridinyl bisphosphonates
US8882740B2 (en) * 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
US10365415B2 (en) * 2013-12-19 2019-07-30 3M Innovative Properties Company Articles comprising self-assembled layers comprising nanoparticles with a phosphorous surface treatment
CN106361701B (zh) * 2016-08-31 2019-08-27 上海交通大学 一种脂质体药物载体及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3751372A (en) 1971-06-18 1973-08-07 Hercules Inc Scale and corrosion control in circulating water using polyphosphates and organophonic acids
GB1508772A (en) 1975-04-04 1978-04-26 Shell Int Research Biologically active compositions
DD150744A1 (de) 1980-04-02 1981-09-16 Sigurd Wobst Verfahren zur kontinuierlichen herstellung von cycloalkylhydroperoxiden
IT1201087B (it) 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
DE3434667A1 (de) * 1984-09-21 1986-04-03 Henkel KGaA, 4000 Düsseldorf 4-dimethylamino-1-hydroxybutan-1,1-diphosphonsaeure, deren wasserloesliche salze, verfahren zu ihrer herstellung sowie ihre verwendung
IT1187828B (it) * 1985-05-24 1987-12-23 Gentili Ist Spa Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
JPS63165457A (ja) 1986-12-27 1988-07-08 Lion Corp 導電性樹脂組成物
JPS63286478A (ja) 1987-05-19 1988-11-24 Lion Corp 導電性塗料組成物
DD273650A1 (de) 1988-07-01 1989-11-22 Robotron Elektronik Verfahren zur chemischen anschlagvernicklung von kupferstrukturen auf dielektrika
HUT63323A (en) 1990-07-13 1993-08-30 Procter & Gamble Composition against dental deposits, comprissing azacycloalkane diphosphonates
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
CA2077312C (en) * 1992-09-01 2000-02-08 Ronald L. Oleka Condensate polisher regenerant system
JPH06100576A (ja) * 1992-09-21 1994-04-12 Kirin Brewery Co Ltd 骨粗鬆症治療剤または予防剤
JP3238304B2 (ja) * 1995-08-11 2001-12-10 三菱重工業株式会社 スケール溶解液
JP3445426B2 (ja) 1995-12-26 2003-09-08 花王株式会社 高吸水性樹脂組成物

Also Published As

Publication number Publication date
ATE251631T1 (de) 2003-10-15
IT1293305B1 (it) 1999-02-16
JP3681637B2 (ja) 2005-08-10
EP0994884B1 (en) 2003-10-08
DE69818823D1 (de) 2003-11-13
HUP0004679A2 (hu) 2001-08-28
PT994884E (pt) 2004-02-27
ES2207853T3 (es) 2004-06-01
CA2303210A1 (en) 1999-01-21
ITMI971628A0 (enExample) 1997-07-09
IL133172A0 (en) 2001-03-19
DK0994884T3 (da) 2004-02-16
ITMI971628A1 (it) 1999-01-09
BR9810561A (pt) 2000-08-15
WO1999002539A1 (en) 1999-01-21
KR100396036B1 (ko) 2003-08-27
AU8806798A (en) 1999-02-08
EP0994884A1 (en) 2000-04-26
DE69818823T2 (de) 2004-05-06
IL133172A (en) 2005-03-20
HUP0004679A3 (en) 2002-04-29
CN1261892A (zh) 2000-08-02
JP2001509510A (ja) 2001-07-24
KR20010021577A (ko) 2001-03-15
US6410782B1 (en) 2002-06-25

Similar Documents

Publication Publication Date Title
CN1161363C (zh) 用于治疗骨质疏松症的双膦酸盐
CN1066713C (zh) 茋衍生物和含有它们的药物组合物
JP3657516B2 (ja) 感染症の治療および予防処置のための有機リン化合物の使用
CN1402737A (zh) 6－巯基环糊精衍生物用于药物诱导的神经肌肉麻醉的反转试剂
JP2002531497A5 (enExample)
EP2691402B1 (fr) Derives d'acide hydroxybisphosphonique bifonctionnels
JP2002520419A (ja) リン有機化合物およびその使用
US6753324B2 (en) Phosphorous organic compounds and their use
AU754862B2 (en) Use of bisphosphonates for the prevention and treatment of infectious processes
CN1810816A (zh) 一组具有抑制hiv－1/hbv病毒复制活性的替诺福韦单酯化合物
CN1045792A (zh) 新颖酯类的制造方法
CN1149830A (zh) 用作治疗剂的吡啶基二膦酸酯
US6534489B1 (en) Organophosphorus compounds and the use thereof
CN1331695A (zh) 有机磷化合物及其用途
CN1617883A (zh) 苯并氮杂环庚三烯化合物的固体盐及其在制备药物化合物中的应用
OA11655A (en) Use of organophosphorous compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants.
CN1337881A (zh) 有机磷化合物预防或治疗感染的应用
CN86105154A (zh) 偕-二卤代-1，8-二氨基-4-氮杂-辛烷的制备方法
CN1079473A (zh) N-磷酰小肽
CN1012815B (zh) 制备偕-二卤代-和四卤代-1，12-二氨基-4，9-二氮杂-十二烷的方法
JP2007536318A5 (enExample)
CN1427844A (zh) 双－(n,n′－双－(2－卤代乙基)氨基)氨基磷酸酯作为抗肿瘤剂
DE19825585A1 (de) Verwendung von Aminohydrocarbylphosphonsäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen, die durch Parasiten, Pilze oder Viren hervorgerufen werden
CN1096783A (zh) 4-嘧啶酮衍生物的盐及其制备方法和在医疗中的应用
CZ2001989A3 (cs) Použití fosfororganických sloučenin pro výrobu léčiv pro terapeutické a profylaktické ošetřování infekcí nebo jako fungicid, baktericid či herbicid u rostlin

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee